<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2017-05-10" version="200">
<accession>O14757</accession>
<accession>A8K934</accession>
<accession>B4DDD0</accession>
<accession>B4DSK3</accession>
<accession>B5BTY6</accession>
<accession>F5H7S4</accession>
<accession>H2BI51</accession>
<name>CHK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase Chk1</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CHK1 checkpoint homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell cycle checkpoint kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Checkpoint kinase-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CHEK1</name>
<name type="synonym">CHK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Science" volume="277" first="1497" last="1501">
<title>Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.</title>
<authorList>
<person name="Sanchez Y."/>
<person name="Wong C."/>
<person name="Thoma R.S."/>
<person name="Richman R."/>
<person name="Wu Z."/>
<person name="Piwnica-Worms H."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="9278511"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25A; CDC25B AND CDC25C</scope>
<scope>INTERACTION WITH CDC25A; CDC25B AND CDC25C</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
<scope>VARIANT VAL-471</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Curr. Biol." volume="7" first="977" last="986">
<title>Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes.</title>
<authorList>
<person name="Flaggs G."/>
<person name="Plug A.W."/>
<person name="Dunks K.M."/>
<person name="Mundt K.E."/>
<person name="Ford J.C."/>
<person name="Quiggle M.R.E."/>
<person name="Taylor E.M."/>
<person name="Westphal C.H."/>
<person name="Ashley T."/>
<person name="Hoekstra M.F."/>
<person name="Carr A.M."/>
</authorList>
<dbReference type="PubMed" id="9382850"/>
<dbReference type="DOI" id="10.1016/S0960-9822(06)00417-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT VAL-471</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Int. J. Oncol." volume="16" first="731" last="737">
<title>Analysis of the candidate target genes for mutation in microsatellite instability-positive cancers of the colorectum, stomach, and endometrium.</title>
<authorList>
<person name="Semba S."/>
<person name="Ouyang H."/>
<person name="Han S.-Y."/>
<person name="Kato Y."/>
<person name="Horii A."/>
</authorList>
<dbReference type="PubMed" id="10717241"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-471</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="197" last="202">
<title>Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints.</title>
<authorList>
<person name="Pabla N."/>
<person name="Bhatt K."/>
<person name="Dong Z."/>
</authorList>
<dbReference type="PubMed" id="22184239"/>
<dbReference type="DOI" id="10.1073/pnas.1104767109"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Fetal thymus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>VARIANT VAL-471</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLN-156 AND VAL-471</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-471</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT VAL-471</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-471</scope>
<source>
<tissue>Bone marrow</tissue>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="289" last="300">
<title>The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.</title>
<authorList>
<person name="Shieh S.-Y."/>
<person name="Ahn J."/>
<person name="Tamai K."/>
<person name="Taya Y."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="10673501"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TP53</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="750" last="750">
<authorList>
<person name="Shieh S.-Y."/>
<person name="Ahn J."/>
<person name="Tamai K."/>
<person name="Taya Y."/>
<person name="Prives C."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="1448" last="1459">
<title>Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.</title>
<authorList>
<person name="Liu Q."/>
<person name="Guntuku S."/>
<person name="Cui X.-S."/>
<person name="Matsuoka S."/>
<person name="Cortez D."/>
<person name="Tamai K."/>
<person name="Luo G."/>
<person name="Carattini-Rivera S."/>
<person name="DeMayo F."/>
<person name="Bradley A."/>
<person name="Donehower L.A."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="10859164"/>
</citation>
<scope>PHOSPHORYLATION AT SER-345 BY ATR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="154" first="913" last="923">
<title>Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing.</title>
<authorList>
<person name="Feijoo C."/>
<person name="Hall-Jackson C."/>
<person name="Wu R."/>
<person name="Jenkins D."/>
<person name="Leitch J."/>
<person name="Gilbert D.M."/>
<person name="Smythe C."/>
</authorList>
<dbReference type="PubMed" id="11535615"/>
<dbReference type="DOI" id="10.1083/jcb.200104099"/>
</citation>
<scope>FUNCTION IN DNA REPLICATION</scope>
<scope>PHOSPHORYLATION BY ATR</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="4129" last="4139">
<title>ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.</title>
<authorList>
<person name="Zhao H."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="11390642"/>
<dbReference type="DOI" id="10.1128/MCB.21.13.4129-4139.2001"/>
</citation>
<scope>PHOSPHORYLATION AT SER-317 AND SER-345</scope>
<scope>MUTAGENESIS OF ASP-130; SER-317; SER-345; SER-357; SER-366 AND SER-468</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16102" last="16115">
<title>Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach.</title>
<authorList>
<person name="O'Neill T."/>
<person name="Giarratani L."/>
<person name="Chen P."/>
<person name="Iyer L."/>
<person name="Lee C.-H."/>
<person name="Bobiak M."/>
<person name="Kanai F."/>
<person name="Zhou B.-B."/>
<person name="Chung J.H."/>
<person name="Rathbun G.A."/>
</authorList>
<dbReference type="PubMed" id="11821419"/>
<dbReference type="DOI" id="10.1074/jbc.M111705200"/>
</citation>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="35776" last="35777">
<authorList>
<person name="O'Neill T."/>
<person name="Giarratani L."/>
<person name="Chen P."/>
<person name="Iyer L."/>
<person name="Lee C.-H."/>
<person name="Bobiak M."/>
<person name="Kanai F."/>
<person name="Zhou B.-B."/>
<person name="Chung J.H."/>
<person name="Rathbun G.A."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="8552" last="8561">
<title>An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage.</title>
<authorList>
<person name="Heffernan T.P."/>
<person name="Simpson D.A."/>
<person name="Frank A.R."/>
<person name="Heinloth A.N."/>
<person name="Paules R.S."/>
<person name="Cordeiro-Stone M."/>
<person name="Kaufmann W.K."/>
</authorList>
<dbReference type="PubMed" id="12446774"/>
<dbReference type="DOI" id="10.1128/MCB.22.24.8552-8561.2002"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>PHOSPHORYLATION AT SER-317 AND SER-345</scope>
<scope>MUTAGENESIS OF LYS-38</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Nat. Genet." volume="30" first="285" last="289">
<title>BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.</title>
<authorList>
<person name="Yarden R.I."/>
<person name="Pardo-Reoyo S."/>
<person name="Sgagias M."/>
<person name="Cowan K.H."/>
<person name="Brody L.C."/>
</authorList>
<dbReference type="PubMed" id="11836499"/>
<dbReference type="DOI" id="10.1038/ng837"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BRCA1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14795" last="14800">
<title>Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.</title>
<authorList>
<person name="Zhao H."/>
<person name="Watkins J.L."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="12399544"/>
<dbReference type="DOI" id="10.1073/pnas.182557299"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Cancer Cell" volume="3" first="247" last="258">
<title>Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.</title>
<authorList>
<person name="Soerensen C.S."/>
<person name="Syljuaesen R.G."/>
<person name="Falck J."/>
<person name="Schroeder T."/>
<person name="Roennstrand L."/>
<person name="Khanna K.K."/>
<person name="Zhou B.-B."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="12676583"/>
<dbReference type="DOI" id="10.1016/S1535-6108(03)00048-5"/>
</citation>
<scope>FUNCTION IN CDC25A TURNOVER</scope>
<scope>PHOSPHORYLATION AT SER-317 AND SER-345</scope>
<scope>MUTAGENESIS OF SER-317 AND SER-345</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="1676" last="1687">
<title>Human tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.</title>
<authorList>
<person name="Groth A."/>
<person name="Lukas J."/>
<person name="Nigg E.A."/>
<person name="Sillje H.H.W."/>
<person name="Wernstedt C."/>
<person name="Bartek J."/>
<person name="Hansen K."/>
</authorList>
<dbReference type="PubMed" id="12660173"/>
<dbReference type="DOI" id="10.1093/emboj/cdg151"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TLK1</scope>
<scope>PHOSPHORYLATION AT SER-317</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Genes Dev." volume="17" first="3062" last="3074">
<title>SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.</title>
<authorList>
<person name="Jin J."/>
<person name="Shirogane T."/>
<person name="Xu L."/>
<person name="Nalepa G."/>
<person name="Qin J."/>
<person name="Elledge S.J."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="14681206"/>
<dbReference type="DOI" id="10.1101/gad.1157503"/>
</citation>
<scope>FUNCTION IN CDC25A TURNOVER</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="14806" last="14811">
<title>Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on ser-317 in response to ionizing radiation.</title>
<authorList>
<person name="Gatei M."/>
<person name="Sloper K."/>
<person name="Soerensen C."/>
<person name="Syljuaesen R."/>
<person name="Falck J."/>
<person name="Hobson K."/>
<person name="Savage K."/>
<person name="Lukas J."/>
<person name="Zhou B.-B."/>
<person name="Bartek J."/>
<person name="Khanna K.K."/>
</authorList>
<dbReference type="PubMed" id="12588868"/>
<dbReference type="DOI" id="10.1074/jbc.M210862200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-317</scope>
<scope>MUTAGENESIS OF ASP-130; SER-317 AND SER-345</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="21767" last="21773">
<title>Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chen Z."/>
<person name="Gunasekera A.H."/>
<person name="Sowin T.J."/>
<person name="Rosenberg S.H."/>
<person name="Fesik S."/>
<person name="Zhang H."/>
</authorList>
<dbReference type="PubMed" id="12676925"/>
<dbReference type="DOI" id="10.1074/jbc.M300229200"/>
</citation>
<scope>FUNCTION IN CDC25A TURNOVER</scope>
<scope>PHOSPHORYLATION AT SER-345</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="25207" last="25217">
<title>Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on ser-345.</title>
<authorList>
<person name="Jiang K."/>
<person name="Pereira E."/>
<person name="Maxfield M."/>
<person name="Russell B."/>
<person name="Goudelock D.M."/>
<person name="Sanchez Y."/>
</authorList>
<dbReference type="PubMed" id="12676962"/>
<dbReference type="DOI" id="10.1074/jbc.M300070200"/>
</citation>
<scope>INTERACTION WITH YWHAZ AND XPO1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH CHROMATIN</scope>
<scope>PHOSPHORYLATION AT SER-317 AND SER-345</scope>
<scope>MUTAGENESIS OF SER-317; PHE-344; SER-345 AND MET-353</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="29824" last="29829">
<title>Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.</title>
<authorList>
<person name="Hassepass I."/>
<person name="Voit R."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="12759351"/>
<dbReference type="DOI" id="10.1074/jbc.M302704200"/>
</citation>
<scope>FUNCTION IN CDC25A TURNOVER</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30057" last="30062">
<title>Human claspin is required for replication checkpoint control.</title>
<authorList>
<person name="Chini C.C.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12766152"/>
<dbReference type="DOI" id="10.1074/jbc.M301136200"/>
</citation>
<scope>INTERACTION WITH CLSPN</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="7488" last="7497">
<title>Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.</title>
<authorList>
<person name="Chen M.-S."/>
<person name="Ryan C.E."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="14559997"/>
<dbReference type="DOI" id="10.1128/MCB.23.21.7488-7497.2003"/>
</citation>
<scope>FUNCTION IN MITOSIS</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25A</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="5927" last="5937">
<title>Suppression of tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.</title>
<authorList>
<person name="Krause D.R."/>
<person name="Jonnalagadda J.C."/>
<person name="Gatei M.H."/>
<person name="Sillje H.H.W."/>
<person name="Zhou B.-B."/>
<person name="Nigg E.A."/>
<person name="Khanna K."/>
</authorList>
<dbReference type="PubMed" id="12955071"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206691"/>
</citation>
<scope>REGULATION OF TLK1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="15387" last="15392">
<title>MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation.</title>
<authorList>
<person name="Wang Y."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="14657349"/>
<dbReference type="DOI" id="10.1073/pnas.2536810100"/>
</citation>
<scope>PHOSPHORYLATION AT SER-317</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="1178" last="1187">
<title>The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.</title>
<authorList>
<person name="Pichierri P."/>
<person name="Rosselli F."/>
</authorList>
<dbReference type="PubMed" id="14988723"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600113"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-345</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="8808" last="8819">
<title>Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains.</title>
<authorList>
<person name="Ng C.-P."/>
<person name="Lee H.C."/>
<person name="Ho C.W."/>
<person name="Arooz T."/>
<person name="Siu W.Y."/>
<person name="Lau A."/>
<person name="Poon R.Y.C."/>
</authorList>
<dbReference type="PubMed" id="14681223"/>
<dbReference type="DOI" id="10.1074/jbc.M312215200"/>
</citation>
<scope>DOMAIN</scope>
<scope>MITOTIC PHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT SER-345</scope>
<scope>MUTAGENESIS OF LYS-38</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="884" last="891">
<title>Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.</title>
<authorList>
<person name="Kraemer A."/>
<person name="Mailand N."/>
<person name="Lukas C."/>
<person name="Syljuaesen R.G."/>
<person name="Wilkinson C.J."/>
<person name="Nigg E.A."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="15311285"/>
<dbReference type="DOI" id="10.1038/ncb1165"/>
</citation>
<scope>FUNCTION IN MITOSIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-130</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="Biochem. J." volume="388" first="705" last="712">
<title>DNA-dependent phosphorylation of Chk1 and claspin in a human cell-free system.</title>
<authorList>
<person name="Clarke C.A.L."/>
<person name="Clarke P.R."/>
</authorList>
<dbReference type="PubMed" id="15707391"/>
<dbReference type="DOI" id="10.1042/BJ20041966"/>
</citation>
<scope>INTERACTION WITH CLSPN</scope>
<scope>PHOSPHORYLATION AT SER-296; SER-317 AND SER-345</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="193" last="204">
<title>Lack of PTEN sequesters CHK1 and initiates genetic instability.</title>
<authorList>
<person name="Puc J."/>
<person name="Keniry M."/>
<person name="Li H.S."/>
<person name="Pandita T.K."/>
<person name="Choudhury A.D."/>
<person name="Memeo L."/>
<person name="Mansukhani M."/>
<person name="Murty V.V.V.S."/>
<person name="Gaciong Z."/>
<person name="Meek S.E.M."/>
<person name="Piwnica-Worms H."/>
<person name="Hibshoosh H."/>
<person name="Parsons R."/>
</authorList>
<dbReference type="PubMed" id="15710331"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.01.009"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="1162" last="1174">
<title>PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.</title>
<authorList>
<person name="Lu X."/>
<person name="Nannenga B."/>
<person name="Donehower L.A."/>
</authorList>
<dbReference type="PubMed" id="15870257"/>
<dbReference type="DOI" id="10.1101/gad.1291305"/>
</citation>
<scope>INTERACTION WITH PPM1D</scope>
<scope>PHOSPHORYLATION AT SER-317 AND SER-345</scope>
<scope>DEPHOSPHORYLATION BY PPM1D</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="1684" last="1695">
<title>p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.</title>
<authorList>
<person name="Ou Y.-H."/>
<person name="Chung P.-H."/>
<person name="Sun T.-P."/>
<person name="Shieh S.-Y."/>
</authorList>
<dbReference type="PubMed" id="15659650"/>
<dbReference type="DOI" id="10.1091/mbc.E04-08-0689"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TP53</scope>
<scope>FUNCTION IN TP53-DEPENDENT TRANSCRIPTION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="3109" last="3116">
<title>Coupling of human circadian and cell cycles by the timeless protein.</title>
<authorList>
<person name="Uensal-Kacmaz K."/>
<person name="Mullen T.E."/>
<person name="Kaufmann W.K."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="15798197"/>
<dbReference type="DOI" id="10.1128/MCB.25.8.3109-3116.2005"/>
</citation>
<scope>INTERACTION WITH TIMELESS</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Nat. Cell Biol." volume="7" first="195" last="201">
<title>The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.</title>
<authorList>
<person name="Soerensen C.S."/>
<person name="Hansen L.T."/>
<person name="Dziegielewski J."/>
<person name="Syljuaesen R.G."/>
<person name="Lundin C."/>
<person name="Bartek J."/>
<person name="Helleday T."/>
</authorList>
<dbReference type="PubMed" id="15665856"/>
<dbReference type="DOI" id="10.1038/ncb1212"/>
</citation>
<scope>FUNCTION IN HOMOLOGOUS RECOMBINATION REPAIR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF RAD51</scope>
<scope>INTERACTION WITH RAD51</scope>
<scope>MUTAGENESIS OF SER-317 AND SER-345</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1065" last="1070">
<title>DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint.</title>
<authorList>
<person name="Huang X."/>
<person name="Tran T."/>
<person name="Zhang L."/>
<person name="Hatcher R."/>
<person name="Zhang P."/>
</authorList>
<dbReference type="PubMed" id="15650047"/>
<dbReference type="DOI" id="10.1073/pnas.0409130102"/>
</citation>
<scope>FUNCTION IN MITOTIC EXIT</scope>
<scope>PHOSPHORYLATION AT SER-345</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="1207" last="1218">
<title>14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.</title>
<authorList>
<person name="Jin Y."/>
<person name="Dai M.S."/>
<person name="Lu S.Z."/>
<person name="Xu Y."/>
<person name="Luo Z."/>
<person name="Zhao Y."/>
<person name="Lu H."/>
</authorList>
<dbReference type="PubMed" id="16511572"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601010"/>
</citation>
<scope>FUNCTION IN TP53 ACTIVATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF MDM4</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="33276" last="33282">
<title>Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16963448"/>
<dbReference type="DOI" id="10.1074/jbc.M604373200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CLSPN</scope>
<scope>INTERACTION WITH CLSPN</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="2083" last="2093">
<title>Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage.</title>
<authorList>
<person name="Inoue Y."/>
<person name="Kitagawa M."/>
<person name="Taya Y."/>
</authorList>
<dbReference type="PubMed" id="17380128"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601652"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RB1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="3098" last="3108">
<title>Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.</title>
<authorList>
<person name="Wang X."/>
<person name="Kennedy R.D."/>
<person name="Ray K."/>
<person name="Stuckert P."/>
<person name="Ellenberger T."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="17296736"/>
<dbReference type="DOI" id="10.1128/MCB.02357-06"/>
</citation>
<scope>FUNCTION IN DNA CROSS-LINKS REPAIR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FANCE</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Cell" volume="133" first="864" last="877">
<title>Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.</title>
<authorList>
<person name="Sidi S."/>
<person name="Sanda T."/>
<person name="Kennedy R.D."/>
<person name="Hagen A.T."/>
<person name="Jette C.A."/>
<person name="Hoffmans R."/>
<person name="Pascual J."/>
<person name="Imamura S."/>
<person name="Kishi S."/>
<person name="Amatruda J.F."/>
<person name="Kanki J.P."/>
<person name="Green D.R."/>
<person name="D'Andrea A.A."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="18510930"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.03.037"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="2705" last="2709">
<title>Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation.</title>
<authorList>
<person name="Lee M.Y."/>
<person name="Kim H.J."/>
<person name="Kim M.A."/>
<person name="Jee H.J."/>
<person name="Kim A.J."/>
<person name="Bae Y.S."/>
<person name="Park J.I."/>
<person name="Chung J.H."/>
<person name="Yun J."/>
</authorList>
<dbReference type="PubMed" id="18728393"/>
<dbReference type="DOI" id="10.4161/cc.7.17.6551"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NEK6</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="1147" last="1152">
<title>Chk1 and Claspin potentiate PCNA ubiquitination.</title>
<authorList>
<person name="Yang X.H."/>
<person name="Shiotani B."/>
<person name="Classon M."/>
<person name="Zou L."/>
</authorList>
<dbReference type="PubMed" id="18451105"/>
<dbReference type="DOI" id="10.1101/gad.1632808"/>
</citation>
<scope>FUNCTION IN REPLICATION FORK MAINTENANCE</scope>
<scope>FUNCTION IN PCNA UBIQUITINATION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3977" last="3985">
<title>The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.</title>
<authorList>
<person name="Bahassi E.M."/>
<person name="Ovesen J.L."/>
<person name="Riesenberg A.L."/>
<person name="Bernstein W.Z."/>
<person name="Hasty P.E."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="18317453"/>
<dbReference type="DOI" id="10.1038/onc.2008.17"/>
</citation>
<scope>FUNCTION IN RAD51-MEDIATED DNA REPAIR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF BRCA2 AND RAD51</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-286; SER-296 AND SER-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="53">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="Cell Res." volume="19" first="458" last="468">
<title>Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.</title>
<authorList>
<person name="Jiang H."/>
<person name="Wu J."/>
<person name="He C."/>
<person name="Yang W."/>
<person name="Li H."/>
</authorList>
<dbReference type="PubMed" id="19223857"/>
<dbReference type="DOI" id="10.1038/cr.2009.14"/>
</citation>
<scope>INTERACTION WITH CDK5RAP3</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2009" name="Mol. Cell" volume="35" first="442" last="453">
<title>The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.</title>
<authorList>
<person name="Zhang Y.-W."/>
<person name="Brognard J."/>
<person name="Coughlin C."/>
<person name="You Z."/>
<person name="Dolled-Filhart M."/>
<person name="Aslanian A."/>
<person name="Manning G."/>
<person name="Abraham R.T."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="19716789"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.06.030"/>
</citation>
<scope>PHOSPHORYLATION AT SER-345</scope>
<scope>UBIQUITINATION AT LYS-436</scope>
<scope>INTERACTION WITH FBXO6</scope>
<scope>MUTAGENESIS OF SER-345; ARG-372; ARG-376; ARG-379 AND LYS-436</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="1247" last="1253">
<title>NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.</title>
<authorList>
<person name="Melixetian M."/>
<person name="Klein D.K."/>
<person name="Soerensen C.S."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="19734889"/>
<dbReference type="DOI" id="10.1038/ncb1969"/>
</citation>
<scope>FUNCTION IN NEK11 PHOSPHORYLATION</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="1971" last="1981">
<title>Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress.</title>
<authorList>
<person name="Sun T.P."/>
<person name="Shieh S.Y."/>
</authorList>
<dbReference type="PubMed" id="19330022"/>
<dbReference type="DOI" id="10.1038/onc.2009.58"/>
</citation>
<scope>INTERACTION WITH FEM1B</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="Cell Cycle" volume="9" first="450" last="455">
<title>NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling.</title>
<authorList>
<person name="Soerensen C.S."/>
<person name="Melixetian M."/>
<person name="Klein D.K."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="20090422"/>
<dbReference type="DOI" id="10.4161/cc.9.3.10513"/>
</citation>
<scope>FUNCTION IN CDC25A DEGRADATION</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-286; SER-296 AND SER-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="62">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280; SER-296; SER-301; SER-331; SER-467 AND SER-468</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="65">
<citation type="journal article" date="2000" name="Cell" volume="100" first="681" last="692">
<title>The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation.</title>
<authorList>
<person name="Chen P."/>
<person name="Luo C."/>
<person name="Deng Y."/>
<person name="Ryan K."/>
<person name="Register J."/>
<person name="Margosiak S."/>
<person name="Tempczyk-Russell A."/>
<person name="Nguyen B."/>
<person name="Myers P."/>
<person name="Lundgren K."/>
<person name="Kan C.-C."/>
<person name="O'Connor P.M."/>
</authorList>
<dbReference type="PubMed" id="10761933"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80704-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-289</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="46609" last="46615">
<title>Structural basis for Chk1 inhibition by UCN-01.</title>
<authorList>
<person name="Zhao B."/>
<person name="Bower M.J."/>
<person name="McDevitt P.J."/>
<person name="Zhao H."/>
<person name="Davis S.T."/>
<person name="Johanson K.O."/>
<person name="Green S.M."/>
<person name="Concha N.O."/>
<person name="Zhou B.-B.S."/>
</authorList>
<dbReference type="PubMed" id="12244092"/>
<dbReference type="DOI" id="10.1074/jbc.M201233200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-289</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2005" name="J. Med. Chem." volume="48" first="4332" last="4345">
<title>Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.</title>
<authorList>
<person name="Foloppe N."/>
<person name="Fisher L.M."/>
<person name="Howes R."/>
<person name="Kierstan P."/>
<person name="Potter A."/>
<person name="Robertson A.G.S."/>
<person name="Surgenor A.E."/>
</authorList>
<dbReference type="PubMed" id="15974586"/>
<dbReference type="DOI" id="10.1021/jm049022c"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-289</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-223 AND MET-312</scope>
</reference>
<comment type="function">
<text>Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C. Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A. Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. Also phosphorylates NEK6. Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination. Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation. Also promotes repair of DNA cross-links through phosphorylation of FANCE. Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A. This may enhance chromatin assembly both in the presence or absence of DNA damage. May also play a role in replication fork maintenance through regulation of PCNA. May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes. May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest.</text>
</comment>
<comment type="function">
<text>Isoform 2: Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text>Activated through phosphorylation predominantly by ATR but also by ATM in response to DNA damage or inhibition of DNA replication. Activation is modulated by several mediators including CLSPN, BRCA1 and FEM1B.</text>
</comment>
<comment type="subunit">
<text evidence="23 29 30 39 40 41 42 43 46 47 48 49">Interacts (phosphorylated by ATR) with RAD51. Interacts with and phosphorylates CLSPN, an adapter protein that regulates the ATR-dependent phosphorylation of CHEK1. Interacts with BRCA1. Interacts with and phosphorylates CDC25A, CDC25B and CDC25C. Interacts with FBXO6, which regulates CHEK1. Interacts with PPM1D, which regulates CHEK1 through dephosphorylation. Interacts with TIMELESS; DNA damage-dependent. Interacts with FEM1B; activates CHEK1 in response to stress. Interacts with TLK1. Interacts with XPO1 and YWHAZ. Isoform 1 associates with isoform 2, the interaction is disrupted upon phosphorylation by ATR. Interacts with CDK5RAP3; antagonizes CHEK1 (PubMed:19223857).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-974439">
<id>P30307</id>
<label>CDC25C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-7669068">
<id>Q95KV1</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
<label>CLSPN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-592789">
<id>O00255</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-9845742">
<id>Q9HCE7-2</id>
<label>SMURF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-2212315">
<id>Q9UNS1</id>
<label>TIMELESS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974488"/>
<interactant intactId="EBI-359832">
<id>P61981</id>
<label>YWHAG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Microtubule organizing center</location>
<location>Centrosome</location>
</subcellularLocation>
<text>Nuclear export is mediated at least in part by XPO1/CRM1. Also localizes to the centrosome specifically during interphase, where it may protect centrosomal CDC2 kinase from inappropriate activation by cytoplasmic CDC25B.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O14757-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O14757-2</id>
<name>2</name>
<name>Chk1-short</name>
<name>Chk1-S</name>
<sequence type="described" ref="VSP_044008 VSP_044009"/>
</isoform>
<isoform>
<id>O14757-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045075"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="49 50">Expressed ubiquitously with the most abundant expression in thymus, testis, small intestine and colon.</text>
</comment>
<comment type="domain">
<text evidence="33">The autoinhibitory region (AIR) inhibits the activity of the kinase domain.</text>
</comment>
<comment type="PTM">
<text evidence="19 20 24 25 26 27 28 29 31 33 35 38 40 42 48">Phosphorylated by ATR in a RAD17-dependent manner in response to ultraviolet irradiation and inhibition of DNA replication. Phosphorylated by ATM in response to ionizing irradiation. ATM and ATR can both phosphorylate Ser-317 and Ser-345 and this results in enhanced kinase activity. Phosphorylation at Ser-345 induces a change in the conformation of the protein, activates the kinase activity and is a prerequisite for interaction with FBXO6 and subsequent ubiquitination at Lys-436. Phosphorylation at Ser-345 also increases binding to 14-3-3 proteins and promotes nuclear retention. Conversely, dephosphorylation at Ser-345 by PPM1D may contribute to exit from checkpoint mediated cell cycle arrest. Phosphorylation at Ser-280 by AKT1/PKB, may promote mono and/or diubiquitination. Also phosphorylated at undefined residues during mitotic arrest, resulting in decreased activity.</text>
</comment>
<comment type="PTM">
<text evidence="15 19 20 24 27 28 29 33 35 38 40 42 48">Ubiquitinated. Mono or diubiquitination promotes nuclear exclusion (By similarity). The activated form (phosphorylated on Ser-345) is polyubiquitinated at Lys-436 by some SCF-type E3 ubiquitin ligase complex containing FBXO6 promoting its degradation. Ubiquitination and degradation are required to terminate the checkpoint and ensure that activated CHEK1 does not accumulate as cells progress through S phase, when replication forks encounter transient impediments during normal DNA replication.</text>
</comment>
<comment type="similarity">
<text evidence="55">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. NIM1 subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/chek1/"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="AF016582">
<property type="protein sequence ID" value="AAC51736.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF032874">
<property type="protein sequence ID" value="AAB88852.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB032387">
<property type="protein sequence ID" value="BAA84577.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="JF289264">
<property type="protein sequence ID" value="AEB71796.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292549">
<property type="protein sequence ID" value="BAF85238.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293143">
<property type="protein sequence ID" value="BAG56691.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK299783">
<property type="protein sequence ID" value="BAG61665.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF527555">
<property type="protein sequence ID" value="AAM78553.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451222">
<property type="protein sequence ID" value="BAG70036.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451345">
<property type="protein sequence ID" value="BAG70159.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001132">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471065">
<property type="protein sequence ID" value="EAW67644.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004202">
<property type="protein sequence ID" value="AAH04202.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017575">
<property type="protein sequence ID" value="AAH17575.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58191.1">
<molecule id="O14757-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81645.1">
<molecule id="O14757-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8459.1">
<molecule id="O14757-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001107593.1">
<molecule id="O14757-1"/>
<property type="nucleotide sequence ID" value="NM_001114121.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001107594.1">
<molecule id="O14757-1"/>
<property type="nucleotide sequence ID" value="NM_001114122.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001231775.1">
<molecule id="O14757-3"/>
<property type="nucleotide sequence ID" value="NM_001244846.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001265.2">
<molecule id="O14757-1"/>
<property type="nucleotide sequence ID" value="NM_001274.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001317357.1">
<molecule id="O14757-2"/>
<property type="nucleotide sequence ID" value="NM_001330428.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016872635.1">
<molecule id="O14757-1"/>
<property type="nucleotide sequence ID" value="XM_017017146.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.24529"/>
<dbReference type="UniGene" id="Hs.595920"/>
<dbReference type="PDB" id="1IA8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="1NVQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="1NVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="1NVS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="1ZLT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.74"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="1ZYS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-273"/>
</dbReference>
<dbReference type="PDB" id="2AYP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=1-269"/>
</dbReference>
<dbReference type="PDB" id="2BR1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2BRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2C3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2C3K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2C3L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2CGU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2CGV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2CGW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2CGX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2E9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="2E9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="2E9P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="2E9U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="2E9V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=2-269"/>
</dbReference>
<dbReference type="PDB" id="2GDO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2GHG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="2HOG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-307"/>
</dbReference>
<dbReference type="PDB" id="2HXL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=2-307"/>
</dbReference>
<dbReference type="PDB" id="2HXQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-307"/>
</dbReference>
<dbReference type="PDB" id="2HY0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=2-307"/>
</dbReference>
<dbReference type="PDB" id="2QHM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="2QHN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="2R0U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="2WMQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2WMX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2X8D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2X8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-276"/>
</dbReference>
<dbReference type="PDB" id="2X8I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2XEY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2XEZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2XF0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YDI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YDJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=1-276"/>
</dbReference>
<dbReference type="PDB" id="2YDK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-276"/>
</dbReference>
<dbReference type="PDB" id="2YER">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=1-276"/>
</dbReference>
<dbReference type="PDB" id="2YEX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.30"/>
<property type="chains" value="A=1-276"/>
</dbReference>
<dbReference type="PDB" id="2YM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="2YWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="3F9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-307"/>
</dbReference>
<dbReference type="PDB" id="3JVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A=2-272"/>
</dbReference>
<dbReference type="PDB" id="3JVS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-272"/>
</dbReference>
<dbReference type="PDB" id="3NLB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="3OT3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.44"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="3OT8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="3PA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="3PA4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="3PA5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="3TKH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="3TKI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="3U9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="4FSM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FSN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=4-280"/>
</dbReference>
<dbReference type="PDB" id="4FSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FSR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FST">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-270"/>
</dbReference>
<dbReference type="PDB" id="4FSU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FSW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FSY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FSZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FT3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FT5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FT7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FT9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4FTU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4GH2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=2-280"/>
</dbReference>
<dbReference type="PDB" id="4HYH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4HYI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4JIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=2-274"/>
</dbReference>
<dbReference type="PDB" id="4QYE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4QYF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4QYG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=1-289"/>
</dbReference>
<dbReference type="PDB" id="4QYH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-289"/>
</dbReference>
<dbReference type="PDB" id="4RVK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4RVL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="4RVM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="5DLS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1-289"/>
</dbReference>
<dbReference type="PDB" id="5F4N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=1-273"/>
</dbReference>
<dbReference type="PDBsum" id="1IA8"/>
<dbReference type="PDBsum" id="1NVQ"/>
<dbReference type="PDBsum" id="1NVR"/>
<dbReference type="PDBsum" id="1NVS"/>
<dbReference type="PDBsum" id="1ZLT"/>
<dbReference type="PDBsum" id="1ZYS"/>
<dbReference type="PDBsum" id="2AYP"/>
<dbReference type="PDBsum" id="2BR1"/>
<dbReference type="PDBsum" id="2BRB"/>
<dbReference type="PDBsum" id="2BRG"/>
<dbReference type="PDBsum" id="2BRH"/>
<dbReference type="PDBsum" id="2BRM"/>
<dbReference type="PDBsum" id="2BRN"/>
<dbReference type="PDBsum" id="2BRO"/>
<dbReference type="PDBsum" id="2C3J"/>
<dbReference type="PDBsum" id="2C3K"/>
<dbReference type="PDBsum" id="2C3L"/>
<dbReference type="PDBsum" id="2CGU"/>
<dbReference type="PDBsum" id="2CGV"/>
<dbReference type="PDBsum" id="2CGW"/>
<dbReference type="PDBsum" id="2CGX"/>
<dbReference type="PDBsum" id="2E9N"/>
<dbReference type="PDBsum" id="2E9O"/>
<dbReference type="PDBsum" id="2E9P"/>
<dbReference type="PDBsum" id="2E9U"/>
<dbReference type="PDBsum" id="2E9V"/>
<dbReference type="PDBsum" id="2GDO"/>
<dbReference type="PDBsum" id="2GHG"/>
<dbReference type="PDBsum" id="2HOG"/>
<dbReference type="PDBsum" id="2HXL"/>
<dbReference type="PDBsum" id="2HXQ"/>
<dbReference type="PDBsum" id="2HY0"/>
<dbReference type="PDBsum" id="2QHM"/>
<dbReference type="PDBsum" id="2QHN"/>
<dbReference type="PDBsum" id="2R0U"/>
<dbReference type="PDBsum" id="2WMQ"/>
<dbReference type="PDBsum" id="2WMR"/>
<dbReference type="PDBsum" id="2WMS"/>
<dbReference type="PDBsum" id="2WMT"/>
<dbReference type="PDBsum" id="2WMU"/>
<dbReference type="PDBsum" id="2WMV"/>
<dbReference type="PDBsum" id="2WMW"/>
<dbReference type="PDBsum" id="2WMX"/>
<dbReference type="PDBsum" id="2X8D"/>
<dbReference type="PDBsum" id="2X8E"/>
<dbReference type="PDBsum" id="2X8I"/>
<dbReference type="PDBsum" id="2XEY"/>
<dbReference type="PDBsum" id="2XEZ"/>
<dbReference type="PDBsum" id="2XF0"/>
<dbReference type="PDBsum" id="2YDI"/>
<dbReference type="PDBsum" id="2YDJ"/>
<dbReference type="PDBsum" id="2YDK"/>
<dbReference type="PDBsum" id="2YER"/>
<dbReference type="PDBsum" id="2YEX"/>
<dbReference type="PDBsum" id="2YM3"/>
<dbReference type="PDBsum" id="2YM4"/>
<dbReference type="PDBsum" id="2YM5"/>
<dbReference type="PDBsum" id="2YM6"/>
<dbReference type="PDBsum" id="2YM7"/>
<dbReference type="PDBsum" id="2YM8"/>
<dbReference type="PDBsum" id="2YWP"/>
<dbReference type="PDBsum" id="3F9N"/>
<dbReference type="PDBsum" id="3JVR"/>
<dbReference type="PDBsum" id="3JVS"/>
<dbReference type="PDBsum" id="3NLB"/>
<dbReference type="PDBsum" id="3OT3"/>
<dbReference type="PDBsum" id="3OT8"/>
<dbReference type="PDBsum" id="3PA3"/>
<dbReference type="PDBsum" id="3PA4"/>
<dbReference type="PDBsum" id="3PA5"/>
<dbReference type="PDBsum" id="3TKH"/>
<dbReference type="PDBsum" id="3TKI"/>
<dbReference type="PDBsum" id="3U9N"/>
<dbReference type="PDBsum" id="4FSM"/>
<dbReference type="PDBsum" id="4FSN"/>
<dbReference type="PDBsum" id="4FSQ"/>
<dbReference type="PDBsum" id="4FSR"/>
<dbReference type="PDBsum" id="4FST"/>
<dbReference type="PDBsum" id="4FSU"/>
<dbReference type="PDBsum" id="4FSW"/>
<dbReference type="PDBsum" id="4FSY"/>
<dbReference type="PDBsum" id="4FSZ"/>
<dbReference type="PDBsum" id="4FT0"/>
<dbReference type="PDBsum" id="4FT3"/>
<dbReference type="PDBsum" id="4FT5"/>
<dbReference type="PDBsum" id="4FT7"/>
<dbReference type="PDBsum" id="4FT9"/>
<dbReference type="PDBsum" id="4FTA"/>
<dbReference type="PDBsum" id="4FTC"/>
<dbReference type="PDBsum" id="4FTI"/>
<dbReference type="PDBsum" id="4FTJ"/>
<dbReference type="PDBsum" id="4FTK"/>
<dbReference type="PDBsum" id="4FTL"/>
<dbReference type="PDBsum" id="4FTM"/>
<dbReference type="PDBsum" id="4FTN"/>
<dbReference type="PDBsum" id="4FTO"/>
<dbReference type="PDBsum" id="4FTQ"/>
<dbReference type="PDBsum" id="4FTR"/>
<dbReference type="PDBsum" id="4FTT"/>
<dbReference type="PDBsum" id="4FTU"/>
<dbReference type="PDBsum" id="4GH2"/>
<dbReference type="PDBsum" id="4HYH"/>
<dbReference type="PDBsum" id="4HYI"/>
<dbReference type="PDBsum" id="4JIK"/>
<dbReference type="PDBsum" id="4QYE"/>
<dbReference type="PDBsum" id="4QYF"/>
<dbReference type="PDBsum" id="4QYG"/>
<dbReference type="PDBsum" id="4QYH"/>
<dbReference type="PDBsum" id="4RVK"/>
<dbReference type="PDBsum" id="4RVL"/>
<dbReference type="PDBsum" id="4RVM"/>
<dbReference type="PDBsum" id="5DLS"/>
<dbReference type="PDBsum" id="5F4N"/>
<dbReference type="ProteinModelPortal" id="O14757"/>
<dbReference type="SMR" id="O14757"/>
<dbReference type="BioGrid" id="107536">
<property type="interactions" value="91"/>
</dbReference>
<dbReference type="DIP" id="DIP-24182N"/>
<dbReference type="IntAct" id="O14757">
<property type="interactions" value="36"/>
</dbReference>
<dbReference type="MINT" id="MINT-1179072"/>
<dbReference type="STRING" id="9606.ENSP00000388648"/>
<dbReference type="BindingDB" id="O14757"/>
<dbReference type="ChEMBL" id="CHEMBL4630"/>
<dbReference type="DrugBank" id="DB07037">
<property type="generic name" value="(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL"/>
</dbReference>
<dbReference type="DrugBank" id="DB07228">
<property type="generic name" value="1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA"/>
</dbReference>
<dbReference type="DrugBank" id="DB07038">
<property type="generic name" value="2-(cyclohexylamino)benzoic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB08779">
<property type="generic name" value="2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol"/>
</dbReference>
<dbReference type="DrugBank" id="DB07959">
<property type="generic name" value="3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07075">
<property type="generic name" value="3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07025">
<property type="generic name" value="3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB06852">
<property type="generic name" value="4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07336">
<property type="generic name" value="4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL"/>
</dbReference>
<dbReference type="DrugBank" id="DB08780">
<property type="generic name" value="6-MORPHOLIN-4-YL-9H-PURINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB05149">
<property type="generic name" value="XL844"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1987"/>
<dbReference type="iPTMnet" id="O14757"/>
<dbReference type="PhosphoSitePlus" id="O14757"/>
<dbReference type="BioMuta" id="CHEK1"/>
<dbReference type="EPD" id="O14757"/>
<dbReference type="MaxQB" id="O14757"/>
<dbReference type="PaxDb" id="O14757"/>
<dbReference type="PeptideAtlas" id="O14757"/>
<dbReference type="PRIDE" id="O14757"/>
<dbReference type="DNASU" id="1111"/>
<dbReference type="Ensembl" id="ENST00000428830">
<molecule id="O14757-1"/>
<property type="protein sequence ID" value="ENSP00000412504"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000438015">
<molecule id="O14757-1"/>
<property type="protein sequence ID" value="ENSP00000388648"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000524737">
<molecule id="O14757-1"/>
<property type="protein sequence ID" value="ENSP00000432890"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000532449">
<molecule id="O14757-3"/>
<property type="protein sequence ID" value="ENSP00000481616"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000534070">
<molecule id="O14757-1"/>
<property type="protein sequence ID" value="ENSP00000435371"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000544373">
<molecule id="O14757-2"/>
<property type="protein sequence ID" value="ENSP00000442317"/>
<property type="gene ID" value="ENSG00000149554"/>
</dbReference>
<dbReference type="GeneID" id="1111"/>
<dbReference type="KEGG" id="hsa:1111"/>
<dbReference type="UCSC" id="uc001qcf.5">
<molecule id="O14757-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1111"/>
<dbReference type="DisGeNET" id="1111"/>
<dbReference type="GeneCards" id="CHEK1"/>
<dbReference type="H-InvDB" id="HIX0201657"/>
<dbReference type="HGNC" id="HGNC:1925">
<property type="gene designation" value="CHEK1"/>
</dbReference>
<dbReference type="HPA" id="HPA044364"/>
<dbReference type="MIM" id="603078">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O14757"/>
<dbReference type="OpenTargets" id="ENSG00000149554"/>
<dbReference type="PharmGKB" id="PA110"/>
<dbReference type="eggNOG" id="KOG0590">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQ0D">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00870000136514"/>
<dbReference type="HOGENOM" id="HOG000216658"/>
<dbReference type="HOVERGEN" id="HBG002590"/>
<dbReference type="InParanoid" id="O14757"/>
<dbReference type="KO" id="K02216"/>
<dbReference type="OMA" id="GGFSKHI"/>
<dbReference type="PhylomeDB" id="O14757"/>
<dbReference type="TreeFam" id="TF351441"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69601">
<property type="pathway name" value="Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75035">
<property type="pathway name" value="Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"/>
</dbReference>
<dbReference type="SignaLink" id="O14757"/>
<dbReference type="SIGNOR" id="O14757"/>
<dbReference type="ChiTaRS" id="CHEK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O14757"/>
<dbReference type="GeneWiki" id="CHEK1"/>
<dbReference type="GenomeRNAi" id="1111"/>
<dbReference type="PRO" id="PR:O14757"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000149554"/>
<dbReference type="CleanEx" id="HS_CHEK1"/>
<dbReference type="ExpressionAtlas" id="O14757">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O14757">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000794">
<property type="term" value="C:condensed nuclear chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035402">
<property type="term" value="F:histone kinase activity (H3-T11 specific)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048096">
<property type="term" value="P:chromatin-mediated maintenance of transcription"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006975">
<property type="term" value="P:DNA damage induced protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031572">
<property type="term" value="P:G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045839">
<property type="term" value="P:negative regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0010569">
<property type="term" value="P:regulation of double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000615">
<property type="term" value="P:regulation of histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046602">
<property type="term" value="P:regulation of mitotic centrosome separation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010767">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd14069">
<property type="entry name" value="STKc_Chk1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034670">
<property type="entry name" value="Chk1_catalytic_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Serine/threonine-protein kinase Chk1" id="PRO_0000085848">
<location>
<begin position="1"/>
<end position="476"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="16">
<location>
<begin position="9"/>
<end position="265"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="16">
<location>
<begin position="15"/>
<end position="23"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CLSPN" evidence="15">
<location>
<begin position="1"/>
<end position="265"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory region">
<location>
<begin position="391"/>
<end position="476"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="130"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="16">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13">
<location>
<position position="286"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11 13 14 40">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 12 13 14">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="20 24 25 26 27 29 31 40 42">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="19 20 24 27 28 29 33 35 38 40 42 48">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="467"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="468"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="48">
<location>
<position position="436"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044008" evidence="53 54">
<location>
<begin position="1"/>
<end position="94"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044009" evidence="53 54">
<original>RIE</original>
<variation>MEK</variation>
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045075" evidence="53">
<location>
<begin position="412"/>
<end position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3731410." id="VAR_021123" evidence="51">
<original>R</original>
<variation>Q</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35817404." id="VAR_040407" evidence="44">
<original>E</original>
<variation>V</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34097480." id="VAR_040408" evidence="44">
<original>V</original>
<variation>M</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs506504." id="VAR_024571" evidence="18 34 37 45 49 50 51 52">
<original>I</original>
<variation>V</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="24 33">
<original>K</original>
<variation>R</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="17 20 21 22 25 32 36 49">
<original>D</original>
<variation>A</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interaction with RAD51; when associated with A-345. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Abrogates nuclear retention upon checkpoint activation. Impairs interaction with FBXO6." evidence="20 25 27 29 39">
<original>S</original>
<variation>A</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances interaction with RAD51; when associated with E-345." evidence="20 25 27 29 39">
<original>S</original>
<variation>E</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs nuclear export." evidence="29">
<original>F</original>
<variation>A</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation." evidence="20 25 27 29 39 48">
<original>S</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances interaction with RAD51; when associated with E-317." evidence="20 25 27 29 39 48">
<original>S</original>
<variation>E</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs nuclear export." evidence="29">
<original>M</original>
<variation>A</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation induced by hydroxyurea." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation induced by hydroxyurea." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-376 and E-379." evidence="48">
<original>R</original>
<variation>E</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-379." evidence="48">
<original>R</original>
<variation>E</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-376." evidence="48">
<original>R</original>
<variation>E</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances stability of the protein, probably by preventing ubiquitination at this site." evidence="48">
<original>K</original>
<variation>R</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation induced by hydroxyurea." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG56691." ref="5" evidence="55">
<original>L</original>
<variation>S</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG61665." ref="4" evidence="55">
<original>D</original>
<variation>G</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG61665." ref="4" evidence="55">
<original>F</original>
<variation>L</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="3"/>
<end position="8"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="9"/>
<end position="17"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="19"/>
<end position="28"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="34"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="42"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="48"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="70"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="79"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="98"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="104"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="153"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="176"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="186"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="216"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="236"/>
<end position="245"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="256"/>
<end position="259"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="263"/>
<end position="266"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2C3J"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2E9U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GDO"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GHG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XEY"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YEX"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3JVR"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HYI"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10673501"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10717241"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10859164"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11390642"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11535615"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11821419"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11836499"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446774"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12588868"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12660173"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676583"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676925"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676962"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12766152"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14657349"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14681206"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14681223"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14988723"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15311285"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15650047"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15665856"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15707391"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15798197"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15870257"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16963448"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19054851"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19223857"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19330022"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19716789"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9278511"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9382850"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="52" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22184239"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000305"/>
<sequence length="476" mass="54434" checksum="0ABD0FAB67E60F67" modified="2011-01-11" version="2">
MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK
MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY
LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK
RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA
LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF
SPVNSASSEENVKYSSSQPEPRTGLSLWDTSPSYIDKLVQGISFSQPTCPDHMLLNSQLL
GTPGSSQNPWQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRR
NNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKIWLPAT
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>